PDGFRα, a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family, is over-expressed in human serous ovarian tumors and is targeted in clinical trials to treat ovarian cancers [32], [33]. This evidence concerns the gene PDGFRA and ovarian cancer.